The effects of microsomal enzyme inducers on thyroid hormone homeostasis and the thyroid gland are of concern. We have investigated the effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism in rats. We have shown that small increases in serum TSH can result in large increases in thyroid follicular cell proliferation. Furthermore, only those microsomal enzyme inducers that increase serum TSH—that is, phenobarbital (PB) and pregnenolone-16α-carbonitrile (PCN)—increase thyroid follicular cell proliferation, whereas those microsomal enzyme inducers that do not increase serum TSH— that is, 3-methylcholanthrene (3MC) and Aroclor 1254 (PCB)—do not increase thyroid follicular cell proliferation. Deiodination does not appear to be the reason why serum T3 concentrations are maintained in microsomal enzyme inducer—treated rats. We have also shown that those microsomal enzyme inducers that increase serum TSH increase T3 UDP-glucuronosyltransferase (UGT) activity, whereas those microsomal enzyme inducers that do not increase serum TSH do not increase T3 UGT activity. This fi nding suggests that induction of T3 glucuronidation, rather than T4 glucuronidation, mediates increases in serum TSH of microsomal enzyme inducer treated rats.
Barter RA, Klaassen CD (1992). Rat liver microsomal UDP-glucuronosyltransferase activity toward thyroxine: Characterization, induction, and form specificity . Toxicol Appl Pharmacol115: 261— 267.
2.
Barter RA, Klaassen CD (1994). Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats. Toxicol Appl Pharmacol128: 9—17.
3.
Becker DV, Robbins J., Beebe GW, Bouville AC, Wachholz BW (1996). Childhood thyroid cancer following the Chernobyl accident: A status report. Endocrinol Metab Clin N Am25: 197—197.
4.
Beetstra JB, van Engelen JG, Karels P., van der Hoek HJ, de Jong M., Docter R., Krenning EP, Hennemann G., Brouwer A., Visser TJ (1991). Thyroxine and 3,3',5-triiodothyronine are glucuronidated in rat liver by different uridine diphosphate-glucuronyltransferases. Endocrinology128: 741—746.
5.
Chanoine JP, Braverman LE, Farwell AP, Safran M., Alex S., Dubord S., Leonard JL (1993). The thyroid gland is a major source of circulating T3 in the rat. J Clin Invest91: 2709—2713.
6.
Christov K., Raichev R. (1972). Experimental thyroid carcinogenesis. Curr Top Pathol56: 79—114.
7.
De Herder WW , Hazenberg MP, Pennock Schroder AM, Oosterlaken AC, Rutgers M., Visser TJ (1989). On the enterohepatic cycle of triiodothyronine in rats; Importance of the intestinal microflora. Life Sci45: 849—856.
8.
De Sandro V. , Chevrier M., Boddaert A., Melcion C., Cordier A., Richert L. (1991). Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats . Toxicol Appl Pharmacol111: 263—278.
9.
Delange F., Ermans A. (1996). Iodine deficiency. In: Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, Braverman LE, Utiger RD (eds). Lippincott-Raven, Philadelphia, pp 296— 316.
10.
Fisher DA (1996). Thyroid physiology in the perinatal period and during childhood. In: Werner and Ingbar's The Thyroid: A Fundamental and Clinical Text, Braverman LE, Utiger RD (eds). Lippincott-Raven , Philadelphia, pp 974—983.
11.
Grebe SK, Hay ID (1995). Follicular thyroid cancer. Endocrinol Metab Clin N Am24: 761—801.
12.
Hiasa Y., Kitahori Y., Konishi N., Enold N., Fujita T. (1983). Effect of varying the duration of exposure to phenobarbital on its enhancement of N-bis(2-hydroxypropyl)nitrosamine-induced thyroid tumorigenesis in male Wistar rats. Carcinogenesis4: 935—937.
13.
Hiasa Y., Kitahori Y., Ohshima M., Fujita T., Yuasa T., Konishi N., Miyashiro A. (1982). Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine . Carcinogenesis3: 1187—1190.
14.
Hood A., Hashmi R., Klaassen CD (1999). Effects of microsomal enzyme inducers on thyroid-follicular cell proliferation, hyperplasia, and hypertrophy. Toxicol Appl Pharmacol160: 163—170.
15.
Hood A., Klaassen CD (2000). Differential effects of microsomal enzyme inducers on thyroxine (T4) and triiodothyronine (T3) glucuronidation . Toxicol Sci55: 78—84.
16.
Hood A., Klaassen CD (2000). Effects of microsomal enzyme inducers on outer-ring deiodinase (ORD) activity in various rat tissues. Toxicol Appl Pharmacol163: 240—248.
17.
Hood A., Liu J., Klaassen CD (1999). Effects of phenobarbital (PB), pregnenolone-16α-carbonitrile (PCN), and propylthiouracil (PTU) on thyroid follicular cell proliferation . Toxicol Sci50: 45—53.
18.
Hood A., Liu J., Liu Y., Gattone V., Naassen CD (1999). Sensitivity of thyroid gland growth to thyroid stimulating hormone (TSH) in rats treated with antithyroid drugs. Toxicol Sci49: 263—271.
19.
Jemec B. (1977). Studies of the tumorigenic effect of two goitrogens . Cancer40: 2188—2202.
20.
Jemec B. (1980). Studies of the goitrogenic and tumorigenic effect of two goitrogens in combination with hypophysectomy or thyroid hormone treatment . Cancer45: 2138—2148.
21.
Kaplan MM (1980). Thyroxine 5'-monodeiodination in rat anterior pituitary homogenates. Endocrinology106: 567—576.
22.
Lindsay S., Nichols CWJr, Chaikoff IL (1966). Induction of benign and malignant thyroid neoplasms in the rat: Induction of thyroid neoplasms by injection of 131-l with or without the feeding of diets containing propylthiouracil and/or desiccated thyroid . Arch Pathol81: 308—316.
23.
Liu J., Liu Y., Barter RA, Klaassen CD (1995). Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: A dose-response study. J Pharmacol Exp Ther273: 977—985.
24.
McClain RM (1989). The significance of hepatic microsomal enzyme induction and altered thyroid function in rats: Implications for thyroid gland neoplasia. Toxicol Pathol17: 294—306.
25.
McClain RM, Levin AA, Posch R., Downing JC (1989). The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol Appl Pharmacol99: 216—228.
26.
McClain RM, Posch RC, Bosakawsld T., Armstrong JM (1988). Studies on the mode of action for thyroid gland tumor promotion in rats by phenobarbital. Toxicol Appl Pharmacol94: 254—265.
27.
Nikiforov Y. , Gnepp DR (1994). Pediatric thyroid cancer after the Chernobyl disaster—Pathomorphologic study of 84 cases (1991— 1992) from the Republic of Belarus. Cancer74: 748—766.
28.
Redmond O., Tuffery AR (1981). Mitotic rate of rat thyroid follicular cells in vivo in response to a single injection of thyrotropin (TSH). Cell Tissue Kinet14: 625—631.
29.
Rutgers M., Heusdens FA, Bonthuis F., de Herder WW, Hazenberg MP, Visser TJ (1989). Enterohepatic circulation of triiodothyronine (T3) in rats: Importance of the microflora for the liberation and reabsorption of T3 from biliary T3 conjugates. Endocrinology125: 2822—2830.
30.
Saito K., Kaneko H., Sato K., Yoshitake A., Yamada H. (1991). Hepatic UDP-glucuronyltransferase(s) activity toward thyroid hormones in rats: Induction and effects on serum thyroid hormone levels following treatment with various enzyme inducers. Toxicol Appl Pharmacol111:99—106.
31.
Taurog A., Dorris ML, Doerge DR (1996). Mechanism of simultaneous iodination and coupling catalyzed by thyroid peroxidase. Arch Biochem Biophys330: 24—32.
32.
Thomas GA, Williams ED (1991). Evidence for and possible mechanisms of non-genotoxic carcinogenesis in the rodent thyroid. Mutat Res248: 357—370.
33.
Van Raaij JA , Kaptein E., Visser TJ, van den Berg KJ (1993). Increased glucuronidation of thyroid hormone in hexachlorobenzene-treated rats. Biochem Pharmacol45: 627 — 631.
34.
Visser TJ (1990). Importance of deiodination and conjugation in the hepatic metabolism of thyroid hormone. In: The Thyroid Gland, Greer MA (ed), Raven Press, New York, pp 255—283.
35.
Visser TJ, Kaptein E., van Toor H., van Raaij JA, van den Berg KJ, Joe CT, van Engelen JG, Brouver A. (1993). Glucuronidation of thyroid hormone in rat liver: Effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions. Endocrinology133: 2177—2186.
36.
Visser TJ, Rutgers M., de Herder WW, Rooda SJ, Hazenberg MP (1988). Hepatic metabolism, biliary clearance and enterohepatic circulation of thyroid hormone. Acta Med Austriaca15(suppl 1) 37—39.
37.
Williams ED (1990). TSH and thyroid cancer . Horm Metab Res Suppl23: 72—75.
38.
Williams ED (1994). Thyroid tumorigenesis . Horm Res42: 31—34.
39.
Wu SY, Reggio R., Florsheim WH (1985). Characterization of thyrotropin- induced increase in iodothyronine monodeiodinating activity in mice. Endocrinology116: 901—908.
40.
Wynford-Thomas D., Stringer BM, Harach HR, Williams ED (1983). Control of growth in the rat thyroid: An example of specifi c desensitization to trophic hormone stimulation. Experientia39: 421—423.
41.
Wynford-Thomas D., Stringer BM, Williams ED (1982). Dissociation of growth and function in the rat thyroid during prolonged goitrogen administration . Acta Endocrinol Copenh101: 210—216.
